RE 79 Pill - white round, 7mm
Pill with imprint RE 79 is White, Round and has been identified as Metoprolol Tartrate 25 mg. It is supplied by Ranbaxy Pharmaceuticals Inc.
Metoprolol is used in the treatment of Heart Failure; Angina; High Blood Pressure; Angina Pectoris Prophylaxis; Heart Attack and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Metoprolol 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RE 79



Metoprolol Tartrate
- Imprint
- RE 79
- Strength
- 25 mg
- Color
- White
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Cardioselective beta blockers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ranbaxy Pharmaceuticals Inc.
- Inactive Ingredients
-
lactose anhydrous,
microcrystalline cellulose,
croscarmellose sodium,
hypromelloses,
magnesium stearate,
polyethylene glycol,
propylene glycol,
silicon dioxide,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
corn starch,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
63304-0579 | Ranbaxy Pharmaceuticals Inc. |
00904-6162 (Discontinued) | Major Pharmaceuticals |
Related images for "RE 79"
More about metoprolol
- Check interactions
- Compare alternatives
- Reviews (650)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: cardioselective beta blockers
- Breastfeeding
- En español
Patient resources
- Metoprolol drug information
- Metoprolol (Intravenous) (Advanced Reading)
- Metoprolol Extended-Release Tablets
Other brands
Professional resources
- Metoprolol monograph
- Metoprolol (FDA)
- Metoprolol Succinate (FDA)
- Metoprolol Succinate ER Capsules (FDA)
- Metoprolol Succinate ER Tablets (FDA)
Other brands
Toprol-XL, Lopressor, Kapspargo Sprinkle
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.